Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INVACARE CORPORATION

(IVC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: Insider at Invacare Gets Stock Award Sells Portion for Taxes Scaling Down, 90-Day Buy Trend

04/07/2021 | 05:24pm EDT


ę MT Newswires 2021
All news about INVACARE CORPORATION
07/26INVACARE CORPORATION : to Host Conference Call and Webcast to Discuss Second Qua..
BU
07/08EXCLUSIVE : German artificial limb maker Ottobock plans blockbuster 2022 IPO - s..
RE
06/28INVACARE CORPORATION : to Participate in the 21st Annual CJS Securities New Idea..
BU
05/25INVACARE : UBS Global Healthcare Conference Presentation 5.25.21
PU
05/21INVACARE : Amendment No. 3 to the Invacare Corporation 2018 Equity Compensation ..
PU
05/21INVACARE CORP : Change in Directors or Principal Officers, Financial Statements ..
AQ
05/18INSIDER TRENDS : Invacare Insider Makes Shares Sale for Tax Slowing 90-Day Buy T..
MT
05/12INVACARE CORPORATION : to Present at the UBS Global Healthcare Virtual Conferenc..
BU
05/06INVACARE : Q1 Earnings Snapshot
AQ
05/05INVACARE : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
More news
Financials (USD)
Sales 2021 903 M - -
Net income 2021 -17,5 M - -
Net Debt 2021 206 M - -
P/E ratio 2021 -14,6x
Yield 2021 -
Capitalization 257 M 257 M -
EV / Sales 2021 0,51x
EV / Sales 2022 0,46x
Nbr of Employees 3 400
Free-Float 84,2%
Chart INVACARE CORPORATION
Duration : Period :
Invacare Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVACARE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 7,35 $
Average target price 16,00 $
Spread / Average Target 118%
EPS Revisions
Managers and Directors
Matthew E. Monaghan Chairman, President & Chief Executive Officer
Kathleen Patricia Leneghan Senior VP, Chief Financial & Accounting Officer
Angie Goodwin Chief Technology & Information Officer
Anthony C. LaPlaca Secretary, Chief Administrative Officer & SVP
C. Martin Harris Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INVACARE CORPORATION-16.76%257
ABBOTT LABORATORIES9.43%212 881
MEDTRONIC PLC11.17%175 003
BECTON, DICKINSON AND COMPANY1.79%74 069
SARTORIUS STEDIM BIOTECH59.10%50 535
HOYA CORPORATION5.22%50 511